Read article – Cites research by Gregory Tsongalis, professor of pathology and laboratory medicine, and director of clinical genomics and advanced technology, whose lab is working to develop a SARAS-CoV-2 LDT. He has been concerned that the FDA’s emergency use authorization standards have been too lax.

Read article – An op-ed co-authored by Priscila Cevallos, Geisel ’23, and Amal Cheema, Geisel ’23, on how the Granite State needs safer voting policies. “Unfortunately, paperless voter registration and streamlined vote-by-mail are not yet found in New Hampshire, despite many attempted legislation changes,” they write.

Read article – Catherine Florio Pipas, a professor of community and family medicine and co-chair of the American Academy of Family Physicians’ leading physician well-being program, is one of the interviewees for a Q&A on physician burnout during COVID-19. Pipas says, “We know that the well-being of family physicians is linked to the well-being of the population. We also know that the burnout in family physicians has an impact, not only on us as individuals but on our health care systems, and as you mentioned, on our patients.”

Read article – Continued coverage of research from Steve Fiering, professor of microbiology and immunology, and Jack Hoopes, professor of surgery and of medicine, on the use of cowpea mosaic virus in cancer-stricken dogs to find a pathway for developing human treatments. “If a treatment works in dog cancer, it has a very good chance of working, at some level, in human patients,” says Hoopes.

Read article – An article reporting that research on a new antibody cancer drug spearheaded by Randolph Noellem, professor of microbiology and immunology, has begun human clinical trials. The drug, CI-8993, is an anti-VISTA (V-domain Ig Suppressor of T-cell Activation) antibody that is designed to target a molecule that keeps the immune system quiet against cancer.

Read article – An announcement that Catherine Florio Pipas, professor of medical education, community and family and medicine, and The Dartmouth Institute for Health Policy and Clinical Practice, will take part in a “Washington Post Live” discussion on how to address the impact of the COVID-19 pandemic on our primary care system and family physicians.

Read article – Quotes Steven Woloshin, professor of medicine, community and family medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice, in an article about false negative COVID-19 tests.  “It’s a big mistake to rely only on tests,” says Woloshin. “You still need masks, social distancing, hand washing, etc. Especially if you’re in an area where there are high rates of COVID.”

Read article – Quotes Steve Fiering, professor of microbiology and immunology, and Jack Hoopes, professor of surgery and of medicine, in a feature story about research they are conducting that explores the efficacy of a new cancer treatment derived from a common plant virus, known as the cowpea mosaic virus. “It’s worked better than radiation by itself, which is a huge positive for us,” says Hoopes. “The immune system is more powerful than we thought.” (Similar coverage in International Business Times and Futurism.)

Read article – Quotes Steven Woloshin, professor of medicine, community and family medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice, in an article about how the spread of the coronavirus inside the White House is a stark reminder of the danger of relying on testing to prevent outbreaks. “It is also very disturbing that even now, all these months into the pandemic, and with a possible second wave looming, that we do not have a better evidence base to guide public health policy,” says Woloshin. “We really need trials so we can learn our way out of this crisis. Not just trials of vaccines and treatments, but also trials establishing the best ways to open schools and universities, restaurants and so on.”

Read article – Quotes Steven Woloshin, professor of medicine, community and family medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice, in an article about Joe Biden’s negative COVID-19 test, and how a negative test doesn’t tell us the virus isn’t there at all, or that it won’t be there in a day or two, even in a few hours. “You’re falsely reassured,” said Woloshin. “You think you don’t carry the virus, and then you may go around and spread it to other people, which can have really serious consequences.”